Aims To summarize the history, development and efficacy of diabetes self-management education on glycaemic control and mental health in adults and children or adolescents with type 1 diabetes and people with type 2 diabetes. A further aim was to review the status of implementation of diabetes self-management education into routine care and outline current gaps in implementation and research. Methods We searched PubMed and Google scholar for German-and English-language articles regarding diabetes selfmanagement education, glycaemic control and mental health, and restricted this search to meta-analyses.
Introduction
Diabetes mellitus is a chronic condition whose long-term prognosis is highly dependent on the self-care behaviour of the affected people. Diabetes self-management education (DSME) has thus become an essential part of diabetes care. A joint position statement of the American Diabetes Association, the American Association of Diabetes Educators and the Academy of Nutrition and Dietetics defined DSME as the process of facilitating the knowledge, skills and ability necessary for diabetes self-care [1] . The concept of DSME has changed in recent decades, from a rather didactical, knowledge-and skill-centred approach to a more selfmanagement-and empowerment-centred approach. This shift has also been mirrored in an increasing interest in psychosocial outcome variables. This is largely attributable to the increase in the amount of psychosocial research in the past 25 years, initiated in part by study groups such as the Psychosocial Aspects in Diabetes (PSAD) study group within the European Association for the Study of Diabetes (EASD) and the Behavioural Research In Diabetes Group Exchange (BRIDGE) in the USA. This psychosocial research identified mental health as an important determinant of selfmanagement [2, 3] that should be addressed with DSME; it is also an important outcome of DSME [4, 5] .
In the present narrative review, building on the review by Chatterjee et al. [6] , we aimed to examine the development and establishment of DSME as an evidenced-based intervention in diabetes. We summarize the updated evidence of DSME on glycaemic control and psychosocial outcomes in people with type 1 and type 2 diabetes. We expand on previous reviews [6, 7] by providing an update on the impact Correspondence to: Norbert Hermanns. E-mail: hermanns@fidam.de of the rapid development of diabetes technology and digitalization on DSME. Real-world data on the implementation reveals gaps in the adoption of DSME in routine care by comparing DSME in different healthcare systems. This and other gaps in research and clinical practice are addressed in the final part of the present review.
For this narrative review we searched PubMed for articles regarding DSME, glycaemic control and mental health, and restricted this search to meta-analyses and systematic reviews (details of the search strategy are described in Box 1 in the Supporting Information). No criteria on publication date were set, and all articles in English or German were included if published before 1 October 2019. We also checked reference lists within relevant articles as well as Google Scholar for additional references.
What we knew in 1995
Elliot Joslin's famous 1923 statement that 'insulin is a remedy primarily for the wise and not for the foolish, whether they be patients or doctors' [8] indicates that the introduction of insulin into diabetes care was accompanied by the recognition that the use of insulin requires specific knowledge and skills. On the basis that 'teaching is cheaper than nursing', as early as the 1930s, Joslin developed teaching materials containing individualized diet plans and insulin dosing schemes, as well as instructions for diabetic foot care and treatment of early acidosis and hypoglycaemia (then called 'insulin reactions') [8] .
The next evolution of diabetes education came with the availability of blood glucose self-monitoring in the late 1970s, enabling intensive insulin therapy which allowed greater flexibility in lifestyle. Philipp Assal and Michael Berger proposed that structured education programmes were necessary to equip people with type 1 diabetes with enough knowledge to engage in intensified insulin therapy [9] . Within the EASD, in 1977, a new study group, the Diabetes Education Study Group was founded, indicating the high level of interest of the EASD in the establishment of diabetes education at that time. A first structured diabetes education programme for groups was developed by Michael Berger and his group [10] , and it focused on the transfer of knowledge and skills regarding strategies for glucose self-control, counting carbohydrates, adapting doses of prandial insulin, and preventing acute complications such as hypoglycaemia and diabetic ketoacidosis. This education programme was highly structured and delivered by a diabetes nurse or diabetes educator to groups of people with type 1 diabetes. As a consequence, diabetes educators were established as a new profession in many countries in Europe. This programme was adopted in modified forms in many countries, for example, Bulgaria, Austria, and later the UK and Australia [10] [11] [12] [13] . An essential part of this movement towards structured diabetes education was the evaluation of its efficacy by controlled studies to establish DSME as an evidence-based treatment. This proved to be beneficial for convincing clinicians as well as decision-makers in the healthcare system of the relevance of diabetes education, and it facilitated the reimbursement of structured education.
What has the past 25 years of research told us?
Over the past 25 years there have been several developments that have had significant implications for DSME. These include changes in the concept of diabetes education and a sharpened awareness of the importance of mental health, both as an outcome of DSME and as a determinant of successful diabetes self-management. There was also growing evidence regarding the efficacy of DSME in type 1 and type 2 diabetes. The last 25 years have also seen a rapid development of diabetes technology and digitization that can both benefit from DSME.
Self-management and empowerment
In 1995, a task force to revise the National Standards for Diabetes Treatment of the American Diabetes Association recommended that diabetes education be renamed, and created the technical term 'diabetes self-management education'. Consequently, the overall objectives of DSME switched to an emphasis on informed decision-making, self-care behaviour, problem-solving, and active collaboration and participation with the healthcare team to improve not only clinical outcomes but also health status, coping with the chronic condition, and quality of life [14] . This approach is designed to provide people with the tools to manage diabetes autonomously, increasing their feeling of control over the chronic condition and its treatment, and, most importantly,
What's new?
• Diabetes education is an established intervention which has changed from a knowledge-and compliancecentred approach to an empowerment-and self-management-centred approach.
• Diabetes self-management education (DSME) is effective in reducing HbA 1c levels in type 1 and type 2 diabetes, although its impact in children and adolescents is smaller.
• There is increased interest in the potential impact of DSME on mental health. The impact of DSME on mental health and psychological outcomes is inconsistent.
• A major challenge is the implementation of DSME in routine clinical practice.
introduces shared decision-making between the healthcare team and those affected [6] . Diabetes education for type 1 diabetes also paved the way for structured diabetes education in type 2 diabetes. In addition to the management of glycaemic control, the treatment of type 2 diabetes requires the management of metabolic risk factors such as weight, lipid levels and hypertension to reduce the risk of cardiovascular complications [5] . In more behaviourally oriented concepts of lifestyle modification, simple advice and recommendations for lifestyle changes were replaced by an analysis of the functionality of certain behaviours. For example, if eating behaviour frequently occurred in response to stressful or boring situations, problem-solving strategies for these specific situations might be more effective than the advice to eat less. A review and meta-analysis by Norris et al. [5] concluded that the shift towards empowerment with a self-managementcentred approach was more effective in people with type 2 diabetes regarding glycaemic and metabolic measurements than the primarily knowledge-and didactic-oriented approach [5] .
Mental health
Another remarkable result of the early review from Norris et al. was the finding that psychological aspects were rarely explicitly addressed, since only six out of 72 studies (8.3%) reported the psychological outcomes of DSME [5] . In the following years, however, there was growing interest in mental health issues in diabetes. In 1994, a working group of the WHO/International Diabetes Federation St Vincent declaration stressed that diabetes treatment should not only improve metabolic measurements, but also encourage psychological well-being in people with diabetes [15] . As epidemiological evidence demonstrates, quality of life in people with diabetes is reduced [16, 17] , and evidence emerged that having diabetes could be a precipitating factor for poor mental health [18] . At the turn of the millennium, depression in diabetes became an important issue as it was evident that rates of depression in diabetes were doubled compared to the general population [19] . Depression also emerged as an independent risk factor for diabetes outcomes such as quality of life, self-management behaviour, morbidity and mortality [18] . This also led to a heightened interest in the effects of DSME on psychosocial outcomes and mental health. Since depression is a rather general concept, with a symptomatology independent from diabetes, a more proximal marker of mental health in diabetes was introduced: diabetes distress [20, 21] . Diabetes distress is viewed as an emotional response to the fact of having diabetes and is caused by an imbalance in diabetes-related stressors and individual coping abilities [18] . Diabetes distress has therefore also become a key target for interventions [18, 22] . This heightened interest in mental health also led to an adjustment in DSME [6] , whereby the psychosocial aspects, such as the emotional aspects of living with diabetes, motivational issues and social support, were now incorporated into structured DSME programmes [18] .
Efficacy of DSME in type 1 diabetes
Glycaemic control is a central and prognostically relevant outcome of all diabetes therapies. As DSME is an integral part of diabetes management, it should also be evaluated by the central outcome used for diabetes therapies: HbA 1c level. As DSME increases the competence and skills of people with diabetes in their treatment, it would also be expected to reduce disease burden and improve psychosocial outcomes. For the evaluation of the efficacy of DSME on HbA 1c and psychosocial outcomes, we concentrated on meta-analytical findings during the last 25 years (for the literature research strategy, see Supporting Information). In type 1 diabetes, we identified two meta-analyses [23, 24] on the effects of DSME on different outcomes. The metaanalysis by Pillay et al. [24] included 36 randomized controlled trials (RCTs) and found an overall significant impact on HbA 1c with a mean reduction of À0.29 percentage points (95% CI À0.45 to 0.13) at the 6-month follow up. The efficacy of DSME in adults [À0.38 (95% CI À0.82 to 0.06)] was higher than that in adolescents or children [À0.26 (95% CI À0.47 to À0.05)]. The impact of DSME on HbA 1c tended to become smaller with longer follow-up periods. In addition, efficacy with regard to HbA 1c also differed with the choice of the control group (usual care vs active control), with fewer studies having an active control group (Table 1) .
The second meta-analysis was limited to children and young people with type 1 diabetes and included 10 RCTs. The studies had mixed follow-up periods that ranged from 2.3 to 24 months. Overall, a non-significant HbA 1c reduction of 0.1% (95% CI À0.4 to 0.2) was observed ( Table 1) . This represents a small effect size of 0.06 (95% CI À0.21 to 0.09) [23] . Both meta-analyses thus indicate that DSME has lower efficacy with regard to glycaemic control in children and adolescents than in adults.
Effects of DSME on psychosocial outcomes were reported significantly less frequently than effects on glycaemic control. Pillay et al. [24] did not find a significant impact of DSME on diabetes-specific and general quality of life, depression, or diabetes distress ( Table 2 ). The metaanalysis by Charalampopoulos et al. [23] surveyed a broader spectrum of psychosocial outcomes, such as selfefficacy, general and diabetes-specific quality of life, diabetes distress and family functioning. No significant effects of DSME on these psychosocial domains was observed. The impact of DSME on psychosocial outcomes appears to be lower than its impact on glycaemic control (Table 1) ; however, the fact that DSME studies are usually not powered for proving effects on psychosocial outcomes as the primary outcome should be taken into account. Lack of statistical power might therefore partially explain this finding [25] .
More recent DSME programmes that also incorporate coaching and cognitive behavioural therapeutic elements had a larger impact on the reduction of diabetes distress, which ranged from 0.47 [26] to 1.13 [13, 27] standard deviations. This might indicate that newer DSME might be better at addressing the negative emotional impact of type 1 diabetes.
Efficacy of DSME on type 2 diabetes
Much more evidence is available regarding the efficacy of DSME in type 2 than in type 1 diabetes. We identified 21 meta-analyses on the efficacy of DSME in type 2 diabetes, which included more than 450 primary studies with a combined total of >74 000 participants . The metaanalytical studies reported results on different follow-up periods ( Table 3) , which ranged from 1 to 24 months. The reduction in HbA 1c within different follow-up periods showed an expected decreasing effect of DSME on HbA 1c with longer follow-up periods in type 2 diabetes as well. Perrin et al. [48] recently published a meta-analysis of the impact of DSME on diabetes distress as a key mental health outcome [48] . A mean reduction in diabetes distress scores of 0.13 standard deviations (95% CI À0.25 to À0.01) was observed, an impact of DSME on diabetes distress in type 2 diabetes which was smaller than that in type 1 diabetes. The differences in the efficacy of DSME on reducing diabetes distress between type 1 and type 2 diabetes could be attributable to several factors, such as the higher rate of comorbidities in type 2 diabetes, the overall deteriorating progression of type 2 diabetes necessitating intensification of therapy, and circumstances of life due to age differences.
The results regarding empowerment and self-efficacy were more positive, with effect sizes of up to 1.21 standard deviations. The impact of DSME on quality of life outcomes are therefore mixed (Table 4 ).
New diabetes technologies
The last 25 years have seen a rapid development of diabetes technologies. Insulin pumps with more functions, improved continuous glucose monitoring (CGM) systems, automated or semi-automated closed-loop systems and digital glucose analysis have provided great opportunities for diabetes care and hold great potential to improve life with diabetes [50, S1]. However, these new diabetes technologies require new expertise, knowledge and skills because they must all still be effectively used by the person with diabetes and carefully monitored or supervised. For example, real-time CGM and intermittently scanned CGM also require skills to process the magnitude of glucose information provided by the systems. This amount of information must be integrated into meaningful treatment decisions while avoiding overreaction in response to single glucose readings. New glycaemic outcome measures such as time in range, time in hypo-or hyperglycaemic range, and glycaemic variability were established and now stand alongside more traditional outcomes such as HbA 1c [S2].
Data from the type 1 registry of the USA showed that the adoption of new technologies is rapidly rising [49] . The use of CGM increased from 6% of people with diabetes in 2012 to 38% in 2017. In children, the use of insulin pump therapy rose to 63% [49] ; however, despite the wide adoption of new technologies, longitudinal real-world data from the type 1 registry showed that HbA 1c values rose from 61.7 mmol/mol to 68.3 mmol/mol during this period. This might indicate 
= measure of heterogeneity of included trials in the meta-analysis. ª 2020 Diabetes UK that technology alone is not a remedy for poor glycaemic control. Exaggerated expectations or perceived barriers to diabetes technologies are important determinants of the longterm implementation, attrition and outcomes of these technologies [S3-S5]. This also poses new challenges for DSME, which should thus also address the psychosocial aspects of using these diabetes technologies.
Digitalization
Digital solutions have become increasingly available in diabetes care and have the ability to support empowerment and self-management. Diabetes apps have the potential to simplify daily diabetes care by providing either feedback to improve self-management or summary reports on glucose data or lifestyle characteristics [S6]. Results of a metaanalysis based on 14 RCTs showed that mobile apps can reduce HbA 1c by À0.36 percentage points (95% CI À0.87 to À0.14) in type 1 diabetes and by À0.49 percentage points (95% CI À0.68 to À0.30) in type 2 diabetes. It is noteworthy that a sub-analysis including only high-quality studies showed a reduction of only À0.1 and À0.41 percentage points, respectively, indicating that such mobile apps might be more effective in type 2 diabetes than in type 1 diabetes [S6].
Web-based interventions can allow consultations between people with diabetes and healthcare professionals via the internet. Many web-based programmes also allow people with diabetes to submit diabetes data (e.g. glucose data), which can then be discussed online with the healthcare provider. A meta-analysis including 19 studies of type 2 diabetes from Zhai et al.
[S7] demonstrated a rather large reduction in HbA 1c of À0.62 percentage points (95% CI À0.82 to À0.42) in these web-based interventions. In addition, 12 studies that provided telephone-or SMS-based feedback saw a similar mean reduction in HbA 1c of À0.53 (95% CI À0.81 to À0.25) percentage points.
The latest developments involve real-time glucose datasharing with healthcare professionals and people from the personal social support system. Thus, new options for diabetes care are constantly evolving to include social media and online communities that facilitate peer-to-peer contact among people with diabetes. This can enhance the experience of social support, knowledge and empowerment of people with diabetes. Online communities are available around the clock, in contrast to traditional DSME group sessions or face-to-face peer support, which rely on appointments. Certainly, the reach of digital solutions is greater than that of traditional DSME and can therefore supplement structured face-to-face DSME in certain groups of people with diabetes with limited access to healthcare. Blended programmes such as the HypoAWARE or REDEEM studies, consisting of a combination of face-to-face and digital solutions, could enrich classic DSME and provide better ongoing support to maintain the benefits of DSME [28,S8] .
Translation into routine care: implementation
For the translation of DSME into routine care, it is important that DSME has the same effect size on study outcomes in real-world settings as it does in more restricted study conditions. In a series of real-world studies, the Dose Adjustment for Normal Eating (DAFNE) study group showed that the magnitude of education effects observed in the original DAFNE RCT [12] can also be replicated under conditions of routine care [13,S9,S10]. The DAFNE study group also showed the stability of study effects over 1 year in real-world settings. In two comparative effectiveness trials, Ehrmann et al.
[S11] and Bergis et al.
[S5] showed that the RCT results of two DSME programmes for people with type 1 diabetes and for insulin pump users could also be replicated in routine care settings. This indicates for type 1 diabetes that the DSME effects found in RCTs can be translated into routine care.
Another important question regarding the translation of DSME into routine care is the extent to which DSME is adopted into such care. The adoption rates of DSME differ among countries. For example, in the UK, the National Diabetes Audit showed somewhat sobering results regarding participation in DSME. Fewer than 10% of people with type 1 or type 2 diabetes had attended DSME, despite DSME being offered to 40% of people with type 1 diabetes and 90% of people with type 2 diabetes. Coates et al.
[S12] showed that the reasons for not participating in DSME were heterogeneous and highly individual.
In North Rhine Westphalia, the most populous region in Germany, 580 000 people with diabetes are registered in a disease management programme for diabetes which defines treatment targets, timing and frequency of medical checkups, and regulates participation in DSME [S13]. Overall, 72.7% of registered people with type 2 diabetes and 90% of registered people with type 1 diabetes participated in structured DSME, showing a much higher participation rate than in the UK.
Explanations for the different uptake of DSME in the UK and Germany are, of course, difficult, since the healthcare systems of these countries differ considerably. Contextual factors such as the availability of diabetes educators on a large scale, a widespread system of secondary care practices offering DSME free of charge for people with diabetes, the integration of DSME in a structured disease management programme, and reimbursement of DSME for healthcare professionals might contribute to the greater adoption of DSME in Germany.
Results from the disease management programme report in Germany, however, showed that 58% of people with type 1 diabetes still fail to attain the glycaemic target established by the German Diabetes Association, despite the relatively high adoption rate of DSME [S13]. This might indicate that the Table 4 Meta-analytical findings on the efficacy of diabetes self-management education on mental-health outcomes in type 2 diabetes ª 2020 Diabetes UK translation of DSME into action in the type 1 diabetes population has room for improvement and that high participation rates in current DSME programmes do not guarantee that glycaemic targets will be attained.
Meta-analysis

What are the current gaps?
The present review revealed several gaps in the efficacy, adoption in routine care, and concept of DSME, and these should be addressed by further researchers and the key stakeholders of the healthcare system. The reviewed evidence regarding the efficacy of DSME in type 1 and type 2 diabetes has indeed shown that DSME has a significant impact on glycaemic control, but the observed improvements were small to medium-sized. For better prevention of long-term diabetes complications, ways to improve the impact of DSME on glycaemic control need to be explored further. This is especially relevant because the effect of DSME on HbA 1c tends to decline with longer follow-up periods; therefore, an ongoing support measure after the completion of DSME might be helpful to prevent a decline in the treatment effect after the completion of DSME. More research is needed to examine whether digital solutions such as apps or online communities might be an important element for this ongoing support.
The reviewed studies clearly indicate lower efficacy of DSME in children and adolescents in terms of glycaemic control and psychosocial outcomes. This represents a clear gap in current research and care. Sources of diabetes distress may vary considerably between adults and children or adolescents because they face very different developmental tasks. This might have consequences for the assessment of diabetes-related distress, as well as for concepts of DSME. In addition, type 1 diabetes in children/adolescents also leads to considerable distress for parents and caregivers, who are in part responsible for diabetes therapy. New DSME concepts might therefore also be necessary to target the parents and caregivers of young children [S14, S15].
The high comorbidity between diabetes and mental health issues and the less pronounced impact of DSME on psychosocial outcomes clearly shows the need to develop effective strategies to improve the impact of DSME on these issues for adults and children. More research is clearly needed to examine whether the integration of psychotherapeutic techniques such as motivational interviewing, cognitive behavioural elements or coaching into DSME programmes might be helpful to increase its efficacy in improving diabetes distress or other psychosocial outcomes.
The psychosocial outcomes of DSME are being assessed with increasing frequency in newer DSME programmes. Currently, a plethora of psychosocial outcomes are being examined, and many different instruments are used. An agreement about a set of mandatory core psychosocial outcome variables assessed in DSME would facilitate the comparability of the psychosocial outcomes of different DSME programmes [S16,S17].
Another key problem is the rather slow implementation of DSME into clinical routine [S18]. Aside from the availability of DSME programmes, several contextual and individual factors might be associated with the slow uptake of DSME in clinical practice. The integration of DSME in structured disease management programmes associated with reimbursement and the availability of trained personnel with expertise in diabetes education and patient-centred care has been found to be helpful for the implementation of DSME in Germany. Healthcare service research may help by examining which elements are useful for the implementation of DSME in routine care.
Large heterogeneity was also apparent among the reviewed studies regarding aspects of DSME programmes such as type of intervention, concepts of DSME, duration and format. The interventions which were included in the studies differed as to whether they emphasized knowledge and skills or selfmanagement and psychological aspects. The lengths of the programmes as well as their format also differed (e.g. one-toone interventions, group education, or mixed interventions). Given this plethora of possible differences between DSME programmes, it is not clear what elements of DSME are most effective. The meta-analysis of Fan et al.
[S19] provides initial results, indicating that interactive delivery methods of longer duration and with more sessions, as well as the incorporation of booster sessions, appear to be more effective in improving metabolic control and self-management behaviour [S19]; however, more research is necessary to clarify the potential mechanisms of action in different populations of people with diabetes. While the meta-analysis by Fan et al.
provides some indication what intervention elements can improve metabolic control, a clear gap in this regard remains in studies analysing which elements and components are necessary to improve mental health outcomes such as diabetes distress.
Currently, there is a lack of evaluated DSME for diabetes technologies. Only two evaluated DSME programmes exist for insulin pump therapy (a modified DAFNE course [S20] and the INPUT programme [26] ) that demonstrated a similar effect on the reduction of HbA 1c (À0.27 and À0.24 percentage points, respectively). In addition, positive effects on the number of severe hypoglycaemia events, diabetes treatment satisfaction, and some domains of quality of life were reported [27,S20] . For the use of CGM systems, there is currently just one DSME programme (named FLASH) which has demonstrated efficacy regarding improved glycaemic control and reduced diabetes distress in an RCT [S21]. In summary, DSME that addresses the technological and psychosocial aspects of diabetes technologies can unfold the full potential of these technologies.
The evaluation of digital solutions is another gap as digital solutions do not necessarily represent a new intervention per se. In many cases, they are simply a new delivery method (telephone, internet or diabetes apps instead of face-to-face delivery methods) for already established interventions. Some studies may therefore overestimate the efficacy of digital solutions because the effects of delivery method (digital vs face-to-face) and content cannot be clearly distinguished. Head-to-head comparisons of interventions with similar content and context but different delivery methods could thus provide more clarity in this regard.
The integration of digital solutions into DSME is also a current gap. It remains an open question as to which groups of people with diabetes profit more from face-to-face intervention than from digital interventions. The results of the cited meta-analyses [S6,S7] on digital solutions showed relatively high efficacy; however, it is not clear if the samples in the studies were representative of the general population of people with diabetes or if the participants were the socalled 'early adopters' of a new technology, a group which is more likely to profit than people with a more sceptical view of digital solutions.
Review limitations
The present review has several limitations which should be kept in mind when interpreting its results. The terms 'diabetes education' or 'DSME' may be used differently in the various studies included in this review. The content of DSME and the definitions of the term can also vary across the included studies. The summary of meta-analytical findings is subject to the same bias as the individual metaanalyses with regard to the comparability of the included studies. It is also possible that a single study was included in more than one meta-analysis; this is especially true for the meta-analyses of type 2 diabetes; however, a quality assessment of all studies included in these meta-analyses would have been beyond the framework of a narrative review. Based on the I 2 statistics as a measure of heterogeneity and number of included RCTs (Tables 1-4) , the effect estimates appear to reliably indicate the effectiveness of DSME. In addition, most studies do not report fidelity measures; therefore, it remains unclear to what extent the theoretical concept of the examined DSME programmes are actually realized and the conduct of the programme was in line with its curriculum. A specific challenge here is that the claim to personalize DSME to the individual needs and problems can challenge the curricular conduct of the DSME programme.
Conclusions
In the last 25 years, DSME has become an established evidence-based intervention which should be an integral part of diabetes treatment in type 1 and type 2 diabetes. The analysis of the current gaps showed small to medium effect sizes of DSME on glycaemic control in adults. These findings are in line with those of Chatterjee et al. [6] . The present review further showed that in children and adolescents even smaller effects of DSME on glycaemic control than in adults were observed. Improving the efficacy of DSME especially in children and adolescents remains a challenge for the future. A major change of DSME to a self-management-and empowerment-oriented approach has broadened the scope of DSME outcomes beyond metabolic and diabetes knowledge to psychological and mental health outcomes. Technological innovations are currently far from rendering DSME obsolete, since their use in daily routines usually involves a certain amount of skills and knowledge and is associated with a number of psychological aspects, all of which can frequently be addressed by DSME. Digitalization can improve the self-management of people with diabetes and provides the possibility of increasing the reach and efficacy of DSME. One major challenge remains the implementation of DSME in routine care. These key findings confirm the key conclusions of the excellent review by Chatterjee et al. [6] that DSME is efficacious in improving glycaemic and mental health outcomes by informing, training and motivating people with diabetes to manage their disease and treatment requirement on their own. This review additionally identified DSME in children, adolescents and young adults as a target for improvement. We also identified DSME regarding diabetes technology as a current gap but found evidence that DSME can improve effective use and acceptance of diabetes technology. Efforts to implement DSME on a large scale might be aided by performing comparisons between countries or healthcare systems with low vs high adoption of DSME into routine care.
The studies included in this review were mainly conducted in western countries with a reasonable healthcare system, therefore, the results are valid primarily for developed countries, and their transferability to less developed countries might be limited. However, since DSME is a cost-effective intervention [6] and can also be performed in countries with lower technological standards, the adoption of DSME in developing countries might also be possible.
With diabetes numbers rising worldwide and the consequent risk of diabetes complications and diabetes-related stress that can affect quality of life and mental health, DSME can be an important pillar in the management of diabetes. Addressing the identified gaps in research and implementation in clinical routine has promising implications for selfmanagement in people with diabetes. B.K. is an advisory board member of Berlin Chemie, Roche Diabetes Care, Novo Nordisk, Medtronic and Ascensia Diabetes Care, has received speakers' honoraria from Berlin Chemie, Novo Nordisk, Roche Diabetes Care, Abbott, Lilly and Ascensia Diabetes Care, and has received grants in support of investigator trials from Berlin Chemie, Abbott and Roche Diabetes Care.
